The Anticancer Fund Amplify Research Grants 2027 support secondary analyses of cancer clinical trial data, offering approximately €50,000 per project.
The call seeks new evidence to improve the use of existing treatments and guide therapeutic decisions for defined patient populations. Projects should answer questions beyond the original trial objectives.
Eligibility and Project Criteria
- The lead applicant’s host institution must be a nonprofit organisation.
- Projects must analyse data from cancer clinical trials.
- Analyses must primarily use prospectively collected trial data.
- Investigated interventions must be available in European clinical practice.
- Research must address clinically relevant treatment questions.
- Main results must be deliverable within 18 months of the award.
Funding Details
- Budget: Approximately €50,000 per project.
- Expected awards: Up to three.
- Research focus: Secondary trial-data analysis to optimise cancer treatment.
Deadline
- Application deadline: January 14, 2027, at 5 p.m. CET.
- Funding decisions: Expected by the end of March 2027.
Further Information
- Official call, application form and guidelines
- Contact: apply@anticancerfund.org
- Applicants are encouraged to discuss project eligibility before preparing their application.